Formed in 2019 through the merger of Sivantos and Widex, WS Audiology combines more than 140 years’ experience in pioneering the use of technology to help people with hearing loss access the sounds that make life wonderful. Our ambition - as a global leader - is to unlock human potential by making wonderful sound part of everyone’s life. We are active in more than 130 countries around the world.
Investor Relations
WSA delivered organic revenue growth of 7% (5% reported) to EUR 2,465 million and reported EBITDA increased by 14% to EUR 480 million in the fiscal year 2022/23.